Voloridge Investment Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Voloridge Investment Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-111,956	Closed	-$4.45M	–	851
2026 Q1	$4.45M	Sell	111,956 -236,323	-68%	-$6.04M	0.02%	695
2025 Q4	$8.71M	Buy	+348,279	New	+$8.82M	0.03%	628
2025 Q3	–	Sell	-39,379	Closed	-$517K	–	1213
2025 Q2	$517K	Buy	+39,379	New	+$499K	﹤0.01%	1079

Voloridge Investment Management's CNTA Position: Q2 2026 in Review

Voloridge Investment Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 111,956 shares — an estimated $4.45M sold.

Voloridge Investment Management first reported a position in CNTA in Q2 2025 and held it in 3 quarters. The position peaked at $8.71M in Q4 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Voloridge Investment Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Voloridge Investment Management sold 111,956 Centessa Pharmaceuticals shares in Q2 2026, an estimated $4.45M.
Voloridge Investment Management first reported a position in Centessa Pharmaceuticals in Q2 2025 and held it in 3 quarters.
Voloridge Investment Management's Centessa Pharmaceuticals position peaked at $8.71M in Q4 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.